Life sciences market in India

Canada has become a global hub for pharmaceutical and medtech innovation, combining strengths in cutting-edge research with advanced infrastructure and technologies. India presents many opportunities related to these strengths, driven by:

• rising healthcare expenditures
• an expanding middle class
• increasing rates of chronic disease
• significant investment in healthcare infrastructure
• urbanization

• Medical technologies (medtech): India's medtech sector is rapidly expanding, but it remains heavily reliant on imports for critical devices such as diagnostic equipment, surgical instruments, and high-end imaging technologies. With rising demand for affordable and advanced medical solutions, India is a promising market for Canadian companies offering such technologies.
• Biopharmaceuticals: India is the third largest producer of pharmaceuticals worldwide. While India has established itself as a global leader in generic drug manufacturing, its biopharmaceutical sector is at an earlier stage of development, creating meaningful openings for Canadian expertise. There is growing demand for collaboration in biologics, vaccines, advanced therapeutics, and biomanufacturing technologies. 

India's life sciences sector continues to expand, supported by growing demand for advanced healthcare solutions and ongoing investment in healthcare infrastructure. The medtech sector remains heavily reliant on imports for critical devices, while India's established pharmaceutical industry is creating opportunities for collaboration in biologics, vaccines, advanced therapeutics, and biomanufacturing technologies. Canadian companies are well positioned to contribute expertise in:

• drug discovery
• biomanufacturing
• clinical trials
• quality-focused biopharmaceutical production

India is an attractive market for Canadian life sciences companies. Given the country's expanding life sciences sector and growing demand for advanced healthcare solutions , India presents many opportunities for Canadian companies in the medtech and biopharmaceutical sub-sectors.

For more information on life sciences in India, please contact india.commerce@international.gc.ca.